Pharmaceutical Executive July 21, 2025

The EVERSANA team discusses its new technology center that has a goal of pharmatizing AI.

While the pharma industry is embracing AI-based technology, it’s still struggling to find the best uses for these programs in its workflows. While the tech has the potential to enhance everything from drug development to marketing, it can also bring complications to these processes. EVERSANA’s Faruk Capan and Scott Snyder spoke with Pharmaceutical Executive about the company’s new AI Accelerator initiative.

How can pharma properly utilize AI?

Pharmaceutical Executive: How does the AI Accelerator work?
Faruk Capan: The EVERSANA AI Accelerator is our dedicated center of excellence designed to harness the power of artificial intelligence across every facet of commercialization. Innovation is embedded in EVERSANA’s...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article